Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-14-079705
Filing Date
2014-03-03
Accepted
2014-03-03 13:42:38
Documents
14
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 10-K d650543d10k.htm 10-K 1396188
2 EX-12 d650543dex12.htm EX-12 33318
3 EX-21.1 d650543dex211.htm EX-21.1 10330
4 EX-23.1 d650543dex231.htm EX-23.1 5853
5 EX-31.1 d650543dex311.htm EX-31.1 6800
6 EX-31.2 d650543dex312.htm EX-31.2 6781
7 EX-32 d650543dex32.htm EX-32 4113
14 GRAPHIC g650543g12i51.jpg GRAPHIC 35105
  Complete submission text file 0001193125-14-079705.txt   13343900

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT dndn-20131231.xml EX-101.INS 2668103
9 XBRL TAXONOMY EXTENSION SCHEMA dndn-20131231.xsd EX-101.SCH 69855
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dndn-20131231_cal.xml EX-101.CAL 71339
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dndn-20131231_def.xml EX-101.DEF 204507
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE dndn-20131231_lab.xml EX-101.LAB 491694
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dndn-20131231_pre.xml EX-101.PRE 440446
Mailing Address 1301 2ND AVE. SUITE 3200 SEATTLE WA 98101
Business Address 1301 2ND AVE. SUITE 3200 SEATTLE WA 98101 206-219-7815
DENDREON CORP (Filer) CIK: 0001107332 (see all company filings)

EIN.: 223203193 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35546 | Film No.: 14659569
SIC: 2834 Pharmaceutical Preparations